Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on treating hearing loss. The centerpiece of the agreement is ...

AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) therapeutics across several disease areas. The collaboration and license ...

The Secrets of How Life Began May Be Hidden Inside the World’s Oldest Rocks Smithsonian researchers trekked to a remote site in northern Canada to collect four-billion-year-old rock samples that ...